H. Oner Et Al. , "Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.," Frontiers in clinical diabetes and healthcare , vol.3, pp.783277, 2022
Oner, H. Et Al. 2022. Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.. Frontiers in clinical diabetes and healthcare , vol.3 , 783277.
Oner, H., Gunhan, H. G., & Gogas Yavuz, D., (2022). Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.. Frontiers in clinical diabetes and healthcare , vol.3, 783277.
Oner, Hatice, Hatice Gizem Gunhan, And DİLEK YAVUZ. "Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.," Frontiers in clinical diabetes and healthcare , vol.3, 783277, 2022
Oner, Hatice Et Al. "Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.." Frontiers in clinical diabetes and healthcare , vol.3, pp.783277, 2022
Oner, H. Gunhan, H. G. And Gogas Yavuz, D. (2022) . "Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.." Frontiers in clinical diabetes and healthcare , vol.3, p.783277.
@article{article, author={Hatice Oner Et Al. }, title={Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience.}, journal={Frontiers in clinical diabetes and healthcare}, year=2022, pages={783277} }